Women’s Health Devices Market Size to Surpass USD 95.16 Billion in 2030, exhibiting a CAGR of 9.3%

Pune, India, July 31, 2023 (GLOBE NEWSWIRE) — According to Fortune Business Insights, global Women’s Health Devices Market Size was valued at USD 47.02 billion in 2022 and is projected to grow from USD 51.01 billion in 2023 to USD 95.16 billion by 2030, exhibiting a CAGR of 9.3% during the forecast period.

There has been a prevalence of health expenditure on women’s health with rising levels of disposable incomes. Female cancer such as breast and ovarian cancer is shifting the focus to adopt new products. New product launches during the forecast period is set to drive the market growth.

This information is provided by Fortune Business Insights™ in its research report titled Women’s Health Devices Market, 2023-2030.

Key Industry Development-

• December 2022: CooperSurgical, Inc. partnered with Ostro for the launching of CooperSurgical’s hormone-free IUD, Paragard. It is a new customer engagement solution. Paragard is an FDA-approved intrauterine device that prevents pregnancy up to 10 years.

Request a Free Sample PDF – https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/women-s-health-devices-market-105732

Key Takeaways –

• Women’s Health Devices Market size in North America was USD 21.43 billion in 2022
• The growth of the women’s health devices market is expected to be driven by an increase in awareness of women’s health issues.
• The demand for a wide variety of women’s health devices has increased due to the high prevalence of female diseases.
• The cancers & other chronic diseases segment is expected to hold a major market share during the projected period.

Discover the Leading Players Featured in the Report-

• Coloplast A/S (Denmark)
• Hologic Inc. (U.S.)
• Boston Scientific Corporation (U.S.)
• ALLERGAN (AbbVie, Inc.) (U.S.)
• BD (Becton, Dickinson, and Company) (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• CooperSurgical Inc. (The Cooper Companies, Inc.) (U.S.)
• Caldera Medical (U.S.)
• Reckitt Benckiser Group PLC (U.K.)

Report Scope & Segmentation:

Browse Complete Report Details- https://www.fortunebusinessinsights.com/women-s-health-devices-market-105732

Drivers & Restraints:

Increasing Awareness For The Women’s Health Issues To Drive Market Growth

Increasing awareness for the women’s health issues is anticipated to drive the women’s health devices market growth. The female population has been experiencing increases in the proportion in the healthcare expenditure. The demand for diagnosis & treatment of women’s health diseases, such as a wide range of female cancers, has increased tremendously over the past few years owing to the substantial growth in the female patient population.

However, lack of awareness and understanding of the women’s health issues is expected to hamper the market growth for women’s health devices.

Segmentation:

By Application

• General Health & Wellness
• Cancers & Other Chronic Diseases
• Reproductive Health
• Pregnancy & Nursing Care
• Pelvic & Uterine Healthcare
• Others

By End-user

• Hospitals & Clinics
• Home Healthcare
• Others

Regional Insights:

North America Held The Largest Share Due To High Demand For Technological Advanced Products

North America is expected to lead the women’s health devices market share due strong healthcare expenditure for women’s health. The market is valued at USD 21.43 billion in 2022 due to demand for technological advanced products which is set to drive the region’s dominance.

Europe market held the second-largest regional market in the 2022 due to strong women’s healthcare expenditure in 2022 in the major European countries. The high prevalence of female cancers in key European countries is expected to drive growth in the region.

Quick Buy – Women’s Health Devices Market Research Report: https://www.fortunebusinessinsights.com/compare-plan/105732

Competitive Landscape:

F. Hoffmann-La Roche Ltd Dominates The Market With Several Products For Female Health Issues
The market has F. Hoffmann-La Roche Ltd. and Boston Scientific Corporation which have strong product portfolio with wide applications. F. Hoffmann-La Roche Ltd dominates the market due to several products catering to female health issues. Boston Scientific Corporation, CooperSurgical Inc., Coloplast A/S, and Hologic Inc. have a strong portfolio dedicated to pelvic health medical devices. Increasing initiatives in the industry is set to rise to several emerging companies that may increase their market share in the forecast period.

FAQs

How big is the Women’s Health Devices Market?

Women’s Health Devices Market size was USD 47.02 billion in 2022. It is expected to reach USD 95.16 billion in 2030.

How fast is the Women’s Health Devices Market growing?

The Women’s Health Devices Market will exhibit a CAGR of 9.3% during the forecast period, 2023-2030.

Related Reports:

Contraceptive Devices Market Size, Share, Revenue Forecast and Opportunities

Point of Care Diagnostics Market Overview, Industry Share and Forecast

Breast Implants Market Size, Share, Opportunities & Analysis

Preeclampsia Diagnostics Market Analysis, Global Size and Industry Share Forecast

In-vitro Diagnostics Market Size, Share, Opportunities and Forecast

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: [email protected]